"Sarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
| Descriptor ID |
D012509
|
| MeSH Number(s) |
C04.557.450.795
|
| Concept/Terms |
Sarcoma- Sarcoma
- Sarcomas
- Sarcoma, Soft Tissue
- Sarcomas, Soft Tissue
- Soft Tissue Sarcoma
- Soft Tissue Sarcomas
Sarcoma, Epithelioid- Sarcoma, Epithelioid
- Epithelioid Sarcoma
- Epithelioid Sarcomas
- Sarcomas, Epithelioid
Sarcoma, Spindle Cell- Sarcoma, Spindle Cell
- Sarcomas, Spindle Cell
- Spindle Cell Sarcoma
- Spindle Cell Sarcomas
|
Below are MeSH descriptors whose meaning is more general than "Sarcoma".
Below are MeSH descriptors whose meaning is more specific than "Sarcoma".
This graph shows the total number of publications written about "Sarcoma" by people in this website by year, and whether "Sarcoma" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 5 | 4 | 9 |
| 1996 | 2 | 2 | 4 |
| 1997 | 5 | 2 | 7 |
| 1998 | 4 | 1 | 5 |
| 1999 | 7 | 0 | 7 |
| 2000 | 5 | 3 | 8 |
| 2001 | 8 | 2 | 10 |
| 2002 | 6 | 3 | 9 |
| 2003 | 9 | 4 | 13 |
| 2004 | 18 | 1 | 19 |
| 2005 | 12 | 3 | 15 |
| 2006 | 15 | 3 | 18 |
| 2007 | 22 | 3 | 25 |
| 2008 | 18 | 3 | 21 |
| 2009 | 17 | 4 | 21 |
| 2010 | 24 | 6 | 30 |
| 2011 | 35 | 7 | 42 |
| 2012 | 40 | 6 | 46 |
| 2013 | 30 | 3 | 33 |
| 2014 | 29 | 5 | 34 |
| 2015 | 41 | 8 | 49 |
| 2016 | 38 | 5 | 43 |
| 2017 | 29 | 8 | 37 |
| 2018 | 38 | 2 | 40 |
| 2019 | 45 | 2 | 47 |
| 2020 | 45 | 5 | 50 |
| 2021 | 52 | 0 | 52 |
| 2022 | 38 | 0 | 38 |
| 2023 | 34 | 1 | 35 |
| 2024 | 23 | 9 | 32 |
Below are the most recent publications written about "Sarcoma" by people in Profiles.
-
The Capicua C1 Domain Is Required for Full Activity of the CIC::DUX4 Fusion Oncoprotein. Cancer Res Commun. 2024 12 01; 4(12):3099-3113.
-
Pazopanib in the real-world setting in soft tissue sarcomas: data from the Italian national registry. ESMO Open. 2024 Dec; 9(12):103995.
-
Implications of Implementing Children's Oncology Group Risk Stratification to Patients With Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical Trial. Pediatr Blood Cancer. 2025 Feb; 72(2):e31436.
-
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial. Lancet. 2024 Nov 23; 404(10467):2053-2064.
-
Proximal and Classic Epithelioid Sarcomas are Distinct Molecular Entities Defined by MYC/GATA3 and SOX17/Endothelial Markers, Respectively. Mod Pathol. 2025 Jan; 38(1):100647.
-
Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities. Clin Cancer Res. 2024 Nov 01; 30(21):4957-4973.
-
High-Grade Progression, Sarcomatous Transformation, and/or Metastasis of Pituitary Neuroendocrine Neoplasms (PitNENs): The UCSF Experience. Endocr Pathol. 2024 Dec; 35(4):338-348.
-
ESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas. Int J Gynecol Cancer. 2024 Oct 07; 34(10):1499-1521.
-
Flipping the Script: Where Are We Now With Preoperative Radiation Therapy for Soft Tissue Sarcoma? Int J Radiat Oncol Biol Phys. 2024 Nov 01; 120(3):615-620.
-
The landscape of drug sensitivity and resistance in sarcoma. Cell Stem Cell. 2024 Oct 03; 31(10):1524-1542.e4.